ファミリアルファエオクロモサイトーマにおける生殖系SDHD変異
Lancet (London, England)
|April 27, 2001
まとめ
SDHD遺伝子の遺伝子変異は,家族性ファエオクロモサイトーマと関連しています. SDHD変異の検査は,家族性,多発性,または早期発症のフェオクロモサイトーマを有する個人に推奨されます.
科学分野:
- エンドクリノロジー エンドクリノロジー
- 遺伝学 遺伝学とは
- 腫瘍学 腫瘍学
背景:
- ファミリアルファエオクロモサイトマの遺伝子は,ほとんど不明のままである.
- ファミリアルヘッド・アンド・ネックパラガングリオマは,サクシネート脱水原酶複合体のサブユニットD (SDHD) の遺伝子変異と関連しています.
- ファミリアルファエオクロモサイトーマの親類におけるSDHDの調査は正当化されています.
関連する概念動画
Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...


